E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain

International Journal of Cancer

Volumn 119, Issue 9, 2006, Pages 2105-2112

  Ashrafi, G Hossein ^a   Haghshenas, Mohammad ^a   Marchetti, Barbara ^a   Campo, M Saveria ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

E5; Heavy chain; HLA class I; HPV; Immunomodulation; Interaction

Indexed keywords

HLA ANTIGEN CLASS 1; PROTEIN E5; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN PRESENTATION; ANTIGENICITY; ARTICLE; CELL SURFACE; DOWN REGULATION; EFFECTOR CELL; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HAPLOTYPE; HEAVY CHAIN; HUMAN PAPILLOMAVIRUS TYPE 16; HYDROPHOBICITY; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

CELL LINE; DNA PRIMERS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MUTAGENESIS; ONCOGENE PROTEINS, VIRAL; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33748850151     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22089     Document Type: Article

References (31)

1. Frazer IH, Thomas R, Zhou J, Leggatt G, Dunn L, McMillan N, Tindle RW, Filgueira L, Manders P, Barnard P, Sharkey M. Potential strategies utilised by papillomavirus to evade host immunity. Immunol Rev 1999;168:131-42.
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
3. Cresswell P, Bangia N, Dick T, Dietrich G. The nature of the MHC class I peptide loading complex. Immunol Rev 1999;172:21-8.
4. Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM, Campo MS. The E5 protein of human papillomavirus type 16 selectively down-regulates surface HLA class. Int J Cancer 2005;113:276-83.
5. Chang JL, Tsao YP, Liu DW, Huang SJ, Lee WH, Chen SL. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix. J Biomed Sci 2001;8:206-13.
6. Kell B, Jewers RJ, Cason J, Pakarian F, Kaye JN, Best JM. Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides. J Gen Virol 1994;75:2451-6.
7. Suprynowicz FA, Campo MS, Schlegel R. Biological activities of papillomavirus E5 proteins. In: Campo MS, ed. Papillomavirus research: from natural history to vaccines and beyond. UK: Caister Academic Press, 2006. 97-113.
8. +-ATPase can be dissociated from the E5- mediated epidermal growth factor receptor overactivation. Oncogene 2000;19:3727-32.
9. Ashrafi GH, Tsirimonaki E, Marchetti B, O'Brien PM, Sibbet GJ, Andrew L, Campo MS. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 2002;21:248-59.
10. Marchetti B, Ashrafi GH, Araibi EH, Ellis SA, Campo MS. The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus. Oncogene 2006;27:2254-63.
11. Marchetti B, Ashrafi GH, Tsirimonaki E, O'Brien PM, Campo MS. The papillomavirus oncoprotein E5 retains the major histocompatibility class I in the Golgi apparatus and prevents its transport to the cell surface. Oncogene 2002;21:7808-16.
12. Alonso A, Reed J. Modelling of the human papillomavirus type 16 E5 protein. Biochim Biophys Acta 2002;1601:9-18.
13. Bubb V, McCance DJ, Schlegel R. DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein. Virology 1988;163:243-6.
14. Auvinen E, Alonso A, Auvinen P. Human papillomavirus type 16 E5 protein colocalizes with the antiapoptotic Bcl-2 protein. Arch Virol 2004;149:1745-59.
15. Hwang E-S, Nottoli T, Dimaio D. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 1995;211:227-33.
16. Araibi EH, Marchetti B, Ashrafi GH, Campo MS. Down-regulation of MHC class I in bovine papillomas. J Gen Virol 2004;85:2809-14.
17. Conrad M, Bubb VJ, Schlegel R. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol 1993;67:6170-8.
18. Goldstein DJ, Kulke R, DiMaio D, Schlegel R. A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase. J Virol 1992;66:405-13.
19. Faccini AM, Cairney M, Ashrafi GH, Finbow ME, Campo MS, Pitts JD. The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. J Virol 1996;70:9041-5.
20. +-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems. Virology 2000;272:315-25.
21. Disbrow GL, Hanover JA, Schlegel R. Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. J Virol 2005;79:5839-46.
22. Straight SW, Herman B, McCance DJ. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 1995;69:3185-92.
23. Straight SW, Hinkle PM, Jewers RJ, McCance DJ. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol 1993;67:4521-32.
24. Kasper MR, Collins KL. Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. J Virol 2003;77:3041-9.
25. Williams M, Roeth JF, Kasper MR, Filzen TM, Collins KL. Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2. J Virol 2005;79:632-6.
26. Cohen G, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, Baltimore D. The selective down-regulation of class I MHC complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999;10:661-71.
27. Lu X, Yu H, Liu SH, Brodsky FM, Peterlin BM. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 1998;8:647-56.
28. Thomsen P, van Deurs B, Norrild B, Kayser L. The HPV16 E5 oncogene inhibits endocytic trafficking. Oncogene 2000;19:6023-32.
29. Fackler O, Luo W, Geyer M, Alberts AA, Peterlin BM. Activation of Vav by Nef induces cytoskeletal rearrangements and dowstream effector functions. Mol Cell 1999;3:729-39.
30. Dickie P, Ramsdell F, Notkins AL, Venkatesan S. Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. Virology 1993;197:431-8.
31. Williams SMG, Disbrow GL, Schlegel R, Lee D, Threadgill DW, Lambert PF. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res 2005;65:6534-42.